PL2302068T3 - Sposób wytwarzania rekombinowanych polipeptydów - Google Patents

Sposób wytwarzania rekombinowanych polipeptydów

Info

Publication number
PL2302068T3
PL2302068T3 PL10009128.9T PL10009128T PL2302068T3 PL 2302068 T3 PL2302068 T3 PL 2302068T3 PL 10009128 T PL10009128 T PL 10009128T PL 2302068 T3 PL2302068 T3 PL 2302068T3
Authority
PL
Poland
Prior art keywords
preparation
recombinant polypeptides
relates
periplasm
polypeptide
Prior art date
Application number
PL10009128.9T
Other languages
English (en)
Inventor
Günter Stempfer
Norbert Palma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28460018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2302068(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2302068T3 publication Critical patent/PL2302068T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
PL10009128.9T 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów PL2302068T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0319601.1A GB0319601D0 (en) 2003-08-20 2003-08-20 Production process

Publications (1)

Publication Number Publication Date
PL2302068T3 true PL2302068T3 (pl) 2016-09-30

Family

ID=28460018

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04764305T PL1658376T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów
PL10009128.9T PL2302068T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04764305T PL1658376T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów

Country Status (9)

Country Link
US (1) US8426168B2 (pl)
EP (2) EP2302068B2 (pl)
JP (1) JP4750030B2 (pl)
AT (1) ATE503003T1 (pl)
DE (1) DE602004031955D1 (pl)
GB (1) GB0319601D0 (pl)
PL (2) PL1658376T3 (pl)
SI (2) SI1658376T1 (pl)
WO (1) WO2005019466A2 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
EP1882743A4 (en) * 2005-05-12 2012-08-01 Ajinomoto Kk PROTEIN PRODUCTION PROCESS
GB201001791D0 (en) * 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201106225D0 (en) * 2011-04-13 2011-05-25 Glaxosmithkline Biolog Sa Fermentation process
WO2013124474A2 (en) 2012-02-23 2013-08-29 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
JP2016501550A (ja) 2012-12-27 2016-01-21 グリコヴァキシン アーゲー Crm197に関する方法及び組成物
SG11201704836XA (en) 2014-12-22 2017-07-28 Ucb Biopharma Sprl Protein manufacture
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
EP3365678A1 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods for culturing cells and kits and apparatus for same
EP4647493A3 (en) 2017-04-27 2026-01-14 Juno Therapeutics, Inc. Oligomeric particle reagents and methods of use thereof
US12522660B2 (en) 2018-10-31 2026-01-13 C3S2 Gmbh Methods for selection and stimulation of cells and apparatus for same
CN111996225A (zh) * 2020-09-18 2020-11-27 深圳科兴药业有限公司 一种利用微生物生产高活性重组人干扰素α2b的发酵方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
US4680262A (en) 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
DE3511011A1 (de) 1985-03-27 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
EP0604580A1 (en) * 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
DE69318909T2 (de) * 1992-09-09 1998-12-24 Mitsui Chemicals, Inc., Tokio/Tokyo Verfahren zur Herstellung von menschlichem Wachstumshormon
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US6337205B1 (en) * 1998-01-06 2002-01-08 Integrated Biosystems, Inc Cryopreservation vial apparatus and methods
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
AU731758B2 (en) * 1998-07-08 2001-04-05 Mitsui Chemicals, Inc. Method for secretory production of human growth hormone
EP1171468B1 (en) * 1999-04-09 2008-07-02 Universität Zürich Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment
KR100360594B1 (ko) * 2000-01-19 2002-11-13 한미약품공업 주식회사 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU2002311620A1 (en) * 2001-07-02 2003-01-21 Insight Biopharmaceuticals Ltd. Methods of making and using expression constructs for the expression of recombinant proteins
ES2529675T3 (es) 2004-11-30 2015-02-24 Merial Ltd. Dispositivos de mezclado para la lisis química de células
WO2011014507A1 (en) 2009-07-27 2011-02-03 The University Of Wyoming Research Corporation Biological clean fuel processing systems and methods
ES2690542T3 (es) 2010-02-04 2018-11-21 Biomarin Pharmaceutical Inc. Método para purificar variantes de fenilalanina amoníaco-liasa procariotas

Also Published As

Publication number Publication date
EP2302068B1 (en) 2016-03-30
WO2005019466A2 (en) 2005-03-03
EP1658376A2 (en) 2006-05-24
US8426168B2 (en) 2013-04-23
ATE503003T1 (de) 2011-04-15
JP2007502609A (ja) 2007-02-15
SI2302068T1 (sl) 2016-07-29
WO2005019466A3 (en) 2005-05-06
DE602004031955D1 (de) 2011-05-05
EP1658376B1 (en) 2011-03-23
EP2302068A1 (en) 2011-03-30
SI1658376T1 (sl) 2011-06-30
EP2302068B2 (en) 2022-10-26
US20060269990A1 (en) 2006-11-30
GB0319601D0 (en) 2003-09-24
JP4750030B2 (ja) 2011-08-17
PL1658376T3 (pl) 2011-08-31

Similar Documents

Publication Publication Date Title
PL1658376T3 (pl) Sposób wytwarzania rekombinowanych polipeptydów
IL187293A (en) Methods for producing glycosylation proteins at site n and host prokaryotic organisms
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
PH12015500528A1 (en) Fc containing polypeptides with altered glycosylation and reduced
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
WO2004048517A3 (en) Method for reducing or preventing modification of a polypeptide in solution
TW200505939A (en) Process for production of cyclic peptides
MX2009012326A (es) Peptidos de señalizacion.
CA2390358A1 (en) Process for rapid solution synthesis of peptides
AU2650597A (en) Novel fas antigen derivatives
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
ZA202304029B (en) Cxcl9 and variants thereof for immunotherapy of cancer diseases
WO2005017174A3 (en) Process for the purification of recombinant polypeptides
DE60207043D1 (de) Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese
AU8847801A (en) Plant polynucleotides encoding novel prenyl proteases
WO2006061174A3 (en) Rhamnose promoter expression system
WO2004039834A3 (en) Recombinant protein variants
WO2002083713A3 (en) Echinocandin process
WO2005066208A3 (en) Method for production of recombinant growth hormone in form of hybrid protein
WO2009083968A8 (en) Novel protein
WO2001055429A3 (en) Method for the manufacture of recombinant trypsin
PH12022550607A1 (en) N-terminal extension sequence for expression of recombinant therapeutic peptides
AU2003226907A8 (en) Method for the preparation of recombinant mammalian heparin-binding protein (hbp)